| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Operating expenses: | |||||||||
Research and development, net | |||||||||
17,204 | 8,293 | 977 | 2,250 | 4,949 | 4,772 | 2,917 | 1,770 | 1,689 | 1,045 |
General and administrative | |||||||||
5,797 | 5,770 | 4,022 | 2,833 | 3,587 | 2,649 | 2,126 | 1,748 | 2,205 | 1,544 |
Financial expenses (income), net | |||||||||
- | - | - | - | - | - | - | - | 151 | 189 |
Other income | |||||||||
- | - | - | - | - | - | - | 0 | 132 | - |
Operating loss | |||||||||
-23,001 | -14,063 | -4,999 | -5,083 | -8,536 | -7,421 | -4,899 | -3,425 | -3,913 | 2,400 |
Total operating costs and expenses | |||||||||
- | - | - | - | - | - | 5,043 | 3,518 | 3,894 | 2,589 |
Financial expenses (income), net | |||||||||
252 | -115 | -47 | -101 | -48 | 1,825 | -144 | -93 | - | - |
Taxes on income (Note 12) | |||||||||
- | - | - | 0 | 0 | 0 | 0 | 5 | 5 | -19 |
Loss from continuing operations | |||||||||
- | - | - | - | - | - | - | -3,430 | -3,918 | 2,419 |
Net loss from discontinued operations | |||||||||
- | - | - | - | - | - | - | 0 | 0 | 0 |
Net loss | |||||||||
-23,253 | -13,948 | -4,952 | -4,982 | -8,488 | -9,246 | -4,899 | -3,430 | -3,918 | -2,419 |
Basic and diluted net loss per share | |||||||||
-1.06 | -0.70 | - | - | - | - | - | - | - | - |
Basic and diluted net loss per share from continuing operations | |||||||||
- | - | -0.26 | -0.27 | -0.46 | -0.68 | 0.46 | 0.02 | -0.03 | 0.03 |
Weighted average number of shares outstanding used in computing basic and diluted net loss per share | |||||||||
21,906 | 19,997 | 18,777 | 18,663 | 18,405 | 13,662 | 10,738 | 137,596 | 120,117 | 89,094 |